Guy Weinberg, MD will be present the 2025 Mohamed Naguib Lecture at the ISAP 2025 Annual Meeting on October 10, 2025.  Dr. Weinberg is a Professor at the Department of Anesthesiology, University of Illinois - College of Medicine, Chicago, Illinois.

Dr. Weinberg is best known for the discovery that infusing lipid emulsion (ILE) can attenuate or reverse local anesthetic systemic toxicity, LAST. This approach is now considered a standard of care for treating LAST. Dr. Weinberg initially trained at UCSF, receiving board certification in Internal Medicine and Medical Genetics before doing a research fellowship at the NIH. He then switched gears and careers to do a residency in Anesthesiology at UVA Charlottesville where he learned regional anesthesia working under Harold Carron, Cosmo DiFazio, and John Rowlingson. After moving to Chicago, where he worked at Michael Reese Hospital and the University of Illinois, a single peculiar clinical event led to studies of novel molecular targets of local anesthetics and eventually to the discovery that ILE can reduce related toxicity. His lab at the Jesse Brown VA focused on this phenomenon and its underlying mechanisms for more than 20 years. Dr. Weinberg chaired the ASRA working group on LAST for more than a decade and helped form the first advisories for treating LAST. He now co-hosts an annual workshop in Telluride, CO where leading scientists from around the world meet to discuss data on a set of genes, YAP and WWTR1 (TAZ), that contribute to many types of cancer.

International Society of Anaesthetic Pharmacology (ISAP), established the Mohamed Naguib Lecture to honor the late Dr. Mohamed Naguib.  Dr. Naguib had a distinguished career in the field of anesthesiology and was a long supporter of ISAP, serving as President of the society. He made significant contributions to the scientific foundation and clinical applications of neuromuscular monitoring. This named lecture is given at each ISAP Annual Meeting.